ALX Oncology Holdings Inc. (ALXO)

NASDAQ: ALXO · Real-Time Price · USD

0.6551

-0.0591 (-8.27%)

At close: Mar 28, 2025, 4:00 PM

0.6777

+0.0226 (3.45%)

Pre-market: Mar 31, 2025, 4:18 AM EDT

ALX Oncology Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2018
Revenue	-	-	-	-	1.18	Upgrade
Revenue Growth (YoY)	-	-	-	-	-75.35%	Upgrade
Cost of Revenue	-	-	-	-	1.08	Upgrade
Gross Profit	-	-	-	-	0.11	Upgrade
Selling, General & Admin	26.09	28.48	29.04	23.39	14.81	Upgrade
Research & Development	116.37	141.8	98.4	60.17	28.96	Upgrade
Operating Expenses	142.47	170.28	127.44	83.56	43.77	Upgrade
Operating Income	-142.47	-170.28	-127.44	-83.56	-43.66	Upgrade
Interest Expense	-1.73	-1.57	-0.24	-0.01	-	Upgrade
Interest & Investment Income	9.37	10.65	4.28	0.09	0.12	Upgrade
Other Non Operating Income (Expenses)	-0.02	0.39	-0.02	-0.01	-1.34	Upgrade
EBT Excluding Unusual Items	-134.85	-160.81	-123.42	-83.48	-44.88	Upgrade
Other Unusual Items	-	-	-	-	-0.62	Upgrade
Pretax Income	-134.85	-160.81	-123.42	-83.48	-45.5	Upgrade
Income Tax Expense	-	-	0.06	-0.02	0.24	Upgrade
Net Income	-134.85	-160.81	-123.48	-83.46	-45.74	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	5.2	Upgrade
Net Income to Common	-134.85	-160.81	-123.48	-83.46	-50.94	Upgrade
Shares Outstanding (Basic)	52	43	41	40	18	Upgrade
Shares Outstanding (Diluted)	52	43	41	40	18	Upgrade
Shares Change (YoY)	21.37%	5.62%	0.97%	118.05%	500.86%	Upgrade
EPS (Basic)	-2.58	-3.74	-3.03	-2.07	-2.76	Upgrade
EPS (Diluted)	-2.58	-3.74	-3.03	-2.07	-2.76	Upgrade
Free Cash Flow	-122.36	-131.64	-90.65	-68.77	-38.32	Upgrade
Free Cash Flow Per Share	-2.35	-3.06	-2.23	-1.71	-2.07	Upgrade
Gross Margin	-	-	-	-	9.05%	Upgrade
Operating Margin	-	-	-	-	-3693.99%	Upgrade
Profit Margin	-	-	-	-	-4309.81%	Upgrade
Free Cash Flow Margin	-	-	-	-	-3241.96%	Upgrade
EBITDA	-141.6	-169.44	-127.09	-83.5	-43.46	Upgrade
D&A For EBITDA	0.87	0.84	0.34	0.05	0.2	Upgrade
EBIT	-142.47	-170.28	-127.44	-83.56	-43.66	Upgrade

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q